Recent studies find that the induction of vessel narrowing, hypoxia, and hemorrhagic necrosis in murine mammary tumors by vascular disrupting agents, such as combretastatin A4, is accompanied by elevated tumor levels of the chemokine CXCL12 and tumor cell repopulation [49]. The gene discussed is CXCL12; the disease is neoplasm.